Literature DB >> 23207169

Predictive value of pleural and serum interleukin-6 levels for pneumonia and hypo-oxygenations after esophagectomy.

Hironori Tsujimoto1, Risa Takahata, Shinsuke Nomura, Isao Kumano, Yusuke Matsumoto, Kazumichi Yoshida, Shuichi Hiraki, Suefumi Aosasa, Satoshi Ono, Junji Yamamoto, Kazuo Hase.   

Abstract

OBJECTIVE: Pulmonary complications after esophagectomy continue to be a significant cause of morbidity and mortality. Although several factors have been implicated to be associated with pulmonary complications after esophagectomy, the prediction of pulmonary complications remains a challenge. The purpose of this study was to evaluate the predictive value of cytokine levels in sera and pleural drainage fluid for pneumonia and hypo-oxygenations following esophagectomy.
METHODS: A total of 66 patients who underwent esophagectomy for esophageal cancer were retrospectively evaluated for preoperative status, surgical procedures, and postoperative systemic response and laboratory data up to postoperative day (POD) 7. Interleukin-6 (IL-6) and IL-8 levels were also examined in patient sera and pleural drainage fluid until POD 5.
RESULTS: Eighteen patients (27.3%) had pneumonia following esophagectomy. Patients with pneumonia had significantly more frequent intraoperative blood transfusions, more frequent re-intubation, longer hospital stays, and higher hospital mortality than those without pulmonary complications. Patients with pneumonia had significantly higher levels of serum and pleural IL-6 immediately after surgery and on POD 1 than those without pneumonia. Univariate and multivariate analyses revealed higher pleural IL-6 levels were associated with postoperative minimum PaO2/FiO2 ratio.
CONCLUSIONS: The elevation of pleural IL-6 levels immediately after surgery and on POD 1 may predict the incidence of pneumonia and the levels of postoperative impaired oxygenation following esophagectomy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23207169     DOI: 10.1016/j.jss.2012.11.015

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  11 in total

Review 1.  Strategies to reduce pulmonary complications after esophagectomy.

Authors:  Teus J Weijs; Jelle P Ruurda; Grard A P Nieuwenhuijzen; Richard van Hillegersberg; Misha D P Luyer
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

2.  Postoperative pneumonia causes the loss of skeletal muscle volume and poor prognosis in patients undergoing esophagectomy for esophageal cancer.

Authors:  Seiichiro Fujishima; Hironori Tsujimoto; Ken Nagata; Hidekazu Sugasawa; Shinsuke Nomura; Nozomi Ito; Manabu Harada; Takao Sugihara; Yusuke Ishibashi; Keita Kouzu; Hiroshi Shinmoto; Yoji Kishi; Hideki Ueno
Journal:  Gen Thorac Cardiovasc Surg       Date:  2020-09-10

3.  Perioperative Predictive Markers for Recurrence of Esophageal Cancer after Esophagectomy.

Authors:  Yoshinori Fujiwara; Masaharu Higashida; Hisako Kubota; Yuko Okamoto; Shumei Mineta; Shunji Endo; Tomio Ueno
Journal:  Gastrointest Tumors       Date:  2021-03-17

4.  Effects of sevoflurane and propofol on the development of pneumonia after esophagectomy: a retrospective cohort study.

Authors:  Guo-Hua Zhang; Wen Wang
Journal:  BMC Anesthesiol       Date:  2017-12-04       Impact factor: 2.217

5.  High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia.

Authors:  Ying Ding; Chu Chu; Yuqin Li; Gen Li; Xiaoli Lei; Weifang Zhou; Zhengrong Chen
Journal:  BMC Infect Dis       Date:  2018-08-29       Impact factor: 3.090

6.  Hyperbilirubinemia predicts the infectious complications after esophagectomy for esophageal cancer.

Authors:  Yusuke Muneoka; Hiroshi Ichikawa; Shin-Ichi Kosugi; Takaaki Hanyu; Takashi Ishikawa; Yosuke Kano; Yoshifumi Shimada; Masayuki Nagahashi; Jun Sakata; Takashi Kobayashi; Hitoshi Kameyama; Kohei Akazawa; Toshifumi Wakai
Journal:  Ann Med Surg (Lond)       Date:  2019-02-21

7.  Clinical usefulness of a perioperative bacteriological culture to treat patients with postoperative pneumonia after esophagectomy.

Authors:  Tomoyuki Matsunaga; Hiroshi Miyata; Keijiro Sugimura; Kei Asukai; Yoshitomo Yanagimoto; Yusuke Takahashi; Akira Tomokuni; Kazuyoshi Yamamoto; Hirofumi Akita; Junichi Nishimura; Hiroshi Wada; Hidenori Takahashi; Masayoshi Yasui; Takeshi Omori; Masayuki Oue; Masahiko Yano
Journal:  Ann Gastroenterol Surg       Date:  2018-09-21

8.  Comparison of short-term outcomes between transthoracic and robot-assisted transmediastinal radical surgery for esophageal cancer: a prospective study.

Authors:  Shuntaro Yoshimura; Kazuhiko Mori; Motonari Ri; Susumu Aikou; Koichi Yagi; Yukinori Yamagata; Masato Nishida; Hiroharu Yamashita; Sachiyo Nomura; Yasuyuki Seto
Journal:  BMC Cancer       Date:  2021-03-31       Impact factor: 4.430

9.  Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial.

Authors:  Jianguo Tang; Wei Long; Lei Yan; Yu Zhang; Juan Xie; Gang Lu; Chunhui Yang
Journal:  BMC Infect Dis       Date:  2013-12-17       Impact factor: 3.090

10.  Impact of reduced skeletal muscle volume on clinical outcome after esophagectomy for esophageal cancer: A retrospective study.

Authors:  Ken Nagata; Hironori Tsujimoto; Hiromi Nagata; Manabu Harada; Nozomi Ito; Kyohei Kanematsu; Shinsuke Nomura; Hiroyuki Horiguchi; Shuichi Hiraki; Kazuo Hase; Junji Yamamoto; Hideki Ueno
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.